Interleukin-2 (IL-2) with high-dose chemotherapy (HDC) and autologous hematopoietic stem-cell transplantation (AHST) for poor-risk metastatic breast cancer (MBC)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6664-6664
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6664-6664
2004 ◽
Vol 22
(14_suppl)
◽
pp. 726-726
2016 ◽
Vol 51
(8)
◽
pp. 1082-1086
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 726-726
2003 ◽
Vol 9
(5)
◽
pp. 330-340
◽
2006 ◽
Vol 37
(11)
◽
pp. 985-987
◽
2000 ◽
Vol 342
(15)
◽
pp. 1069-1076
◽